David Zaccardelli insider trades: Verona Pharma (VRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 1 more company
Open-market buys and sales
50 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | VRNA | ↓ Sell | 208,912 | $13.14 | $2.7M | Direct | Aug 5, 2025 (4d) |
| Jun 11, 2025 | VRNA | ↓ Sell | 400,000 | $11.40 | $4.6M | Direct | Jun 13, 2025 (2d) |
| May 29, 2025 | VRNA | ↓ Sell | 400,000 | $9.34 | $3.7M | Direct | May 29, 2025 (0d) |
| May 2, 2025 | VRNA | ↓ Sell | 587,008 | $9.05 | $5.3M | Direct | May 5, 2025 (3d) |
| Apr 29, 2025 | VRNA | ↓ Sell | 90,360 | $8.98 | $811K | Direct | May 1, 2025 (2d) |
| Dec 6, 2024 | VRNA | ↓ Sell | 870,672 | $5.01 | $4.4M | Direct | Dec 6, 2024 (0d) |
| Dec 2, 2024 | VRNA | ↓ Sell | 125,328 | $5.00 | $627K | Direct | Dec 2, 2024 (0d) |
| Nov 25, 2024 | VRNA | ↓ Sell | 1,600 | $5.00 | $8K | Direct | Nov 26, 2024 (1d) |
| Nov 11, 2024 | VRNA | ↓ Sell | 2,400 | $5.00 | $12K | Direct | Nov 13, 2024 (2d) |
| Nov 4, 2024 | VRNA | ↓ Sell | 141,032 | $4.39 | $619K | Direct | Nov 5, 2024 (1d) |
| Oct 25, 2024 | VRNA | ↓ Sell | 144,816 | $4.38 | $634K | Direct | Oct 25, 2024 (0d) |
| Oct 22, 2024 | VRNA | ↓ Sell | 514,152 | $4.38 | $2.3M | Direct | Oct 22, 2024 (0d) |
| Sep 11, 2024 | VRNA | ↓ Sell | 600,000 | $3.76 | $2.3M | Direct | Sep 13, 2024 (2d) |
| Aug 13, 2024 | VRNA | ↓ Sell | 400,000 | $3.20 | $1.3M | Direct | Aug 14, 2024 (1d) |
| Aug 7, 2023 | VRNA | ↓ Sell | 275,888 | $2.52 | $694K | Direct | Aug 7, 2023 (0d) |
| Aug 2, 2023 | VRNA | ↓ Sell | 179,648 | $2.64 | $475K | Direct | Aug 3, 2023 (1d) |
| May 1, 2023 | VRNA | ↓ Sell | 455,536 | $2.58 | $1.2M | Direct | May 3, 2023 (2d) |
| Feb 1, 2023 | VRNA | ↓ Sell | 432,928 | $2.56 | $1.1M | Direct | Feb 3, 2023 (2d) |
| Dec 20, 2022 | VRNA | ↓ Sell | 600,000 | $2.12 | $1.3M | Direct | Dec 21, 2022 (1d) |
| Nov 1, 2022 | VRNA | ↓ Sell | 32,904 | $1.67 | $55K | Direct | Nov 3, 2022 (2d) |
| Aug 9, 2022 | VRNA | ↓ Sell | 600,000 | $1.75 | $1.1M | Direct | Aug 11, 2022 (2d) |
| Aug 1, 2022 | VRNA | ↓ Sell | 32,904 | $0.70 | $23K | Direct | Aug 3, 2022 (2d) |
| May 3, 2022 | VRNA | ↓ Sell | 32,904 | $0.50 | $16K | Direct | May 5, 2022 (2d) |
| Feb 3, 2022 | VRNA | ↓ Sell | 52,056 | $0.73 | $38K | Direct | Feb 3, 2022 (0d) |
| Nov 2, 2021 | VRNA | ↓ Sell | 52,056 | $0.64 | $33K | Direct | Nov 3, 2021 (1d) |
| Aug 4, 2021 | VRNA | ↓ Sell | 34,400 | $0.75 | $26K | Direct | Aug 4, 2021 (0d) |
| Aug 3, 2021 | VRNA | ↓ Sell | 17,656 | $0.75 | $13K | Direct | Aug 9, 2021 (6d) |
| May 4, 2021 | VRNA | ↓ Sell | 52,056 | $0.81 | $42K | Direct | May 5, 2021 (1d) |
| Mar 1, 2021 | VRNA | ↓ Sell | 43,392 | $1.14 | $50K | Direct | Mar 3, 2021 (2d) |
| Oct 1, 2019 | DOVA | ↓ Sell | 5,275 | $27.90 | $147K | Direct | Oct 2, 2019 (1d) |
| Jul 2, 2019 | DOVA | ↓ Sell | 10,450 | $15.94 | $167K | Direct | Jul 3, 2019 (1d) |
| Dec 20, 2018 | DOVA | ↑ Buy | 10,000 | $6.07 | $61K | Direct | Dec 21, 2018 (1d) |
| May 29, 2018 | MLNT | ↑ Buy | 40,000 | $5.00 | $200K | Direct | May 31, 2018 (2d) |
| Apr 14, 2015 | UTHR | ↓ Sell | 3,250 | $185.82 | $604K | Direct | Apr 14, 2015 (0d) |
| Apr 9, 2015 | UTHR | ↓ Sell | 4,000 | $184.84 | $739K | Direct | Apr 10, 2015 (1d) |
| Apr 7, 2015 | UTHR | ↓ Sell | 4,000 | $179.34 | $717K | Direct | Apr 8, 2015 (1d) |
| Apr 2, 2015 | UTHR | ↓ Sell | 4,000 | $174.73 | $699K | Direct | Apr 3, 2015 (1d) |
| Mar 31, 2015 | UTHR | ↓ Sell | 4,000 | $172.44 | $690K | Direct | Apr 2, 2015 (2d) |
| Mar 26, 2015 | UTHR | ↓ Sell | 4,000 | $167.52 | $670K | Direct | Mar 26, 2015 (0d) |
| Mar 24, 2015 | UTHR | ↓ Sell | 4,500 | $179.51 | $808K | Direct | Mar 24, 2015 (0d) |
| Mar 19, 2015 | UTHR | ↓ Sell | 4,000 | $175.82 | $703K | Direct | Mar 24, 2015 (5d) |
| Mar 17, 2015 | UTHR | ↓ Sell | 4,000 | $177.34 | $709K | Direct | Mar 18, 2015 (1d) |
| Feb 24, 2015 | UTHR | ↓ Sell | 1,458 | $155.16 | $226K | Direct | Feb 24, 2015 (0d) |
| Feb 17, 2015 | UTHR | ↓ Sell | 4,000 | $155.14 | $621K | Direct | Feb 18, 2015 (1d) |
| Feb 10, 2015 | UTHR | ↓ Sell | 4,000 | $146.68 | $587K | Direct | Feb 11, 2015 (1d) |
| Feb 3, 2015 | UTHR | ↓ Sell | 4,000 | $141.99 | $568K | Direct | Feb 4, 2015 (1d) |
| Jan 27, 2015 | UTHR | ↓ Sell | 4,000 | $147.19 | $589K | Direct | Jan 28, 2015 (1d) |
| Jan 20, 2015 | UTHR | ↓ Sell | 4,000 | $146.48 | $586K | Direct | Jan 22, 2015 (2d) |
| Jan 13, 2015 | UTHR | ↓ Sell | 3,000 | $134.71 | $404K | Direct | Jan 14, 2015 (1d) |
| Jan 6, 2015 | UTHR | ↓ Sell | 3,000 | $124.93 | $375K | Direct | Jan 7, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Zaccardelli's insider trades
David Zaccardelli is President and CEO at Verona Pharma (VRNA). Since Jan 6, 2015, David has reported 2 open-market purchases worth $261K and 48 sales worth $45.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (52 filings), shares returned to the company (32 filings), grants and awards (20 filings), shares withheld for taxes (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.